Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2620]

Specific lung cancer screening and treatment policies urgently needed to address international disparities in survival

Specific lung cancer screening and treatment policies urgently needed to address international disparities in...

Real-world increase in biomarker testing in lung cancer patients, registry study reveals

Real-world increase in biomarker testing in lung cancer patients, registry study reveals

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC regardless of PD-L1 expression

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC...

New class of oncogenic fusions in lung and pancreatic cancer

New class of oncogenic fusions in lung and pancreatic cancer

A potential new target for cancer immunotherapies

A potential new target for cancer immunotherapies

Promising approach against treatment-resistant cancer

Promising approach against treatment-resistant cancer

FDA approves 1st, only immunotherapy-based treatment for use before surgery for non-small cell lung cancer

FDA approves 1st, only immunotherapy-based treatment for use before surgery for non-small cell lung cancer

UK's NICE recommends sotorasib for locally advanced or metastatic non-small cell lung cancer (NSCLC) within the cancer drugs fund

UK's NICE recommends sotorasib for locally advanced or metastatic non-small cell lung cancer (NSCLC) within the...

Cancer breakthrough reveals old drugs with new tricks may limit spread

Cancer breakthrough reveals old drugs with new tricks may limit spread

More from ecancer